Willem F. Lems - Publications

Is Zoledronic acid cost-saving in daily practice?

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: May 28, 2026

Pregnancy- and lactation-associated osteoporosis: A position statement of the IAPM, IOF, ECTS, ESCEO, IMS, and EMAS.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Published: April 17, 2026

Effectiveness of Anti-Osteoporotic Medications in the Management of Glucocorticoid-Induced Osteoporosis: A Systematic Review and Network Meta-Analysis on Behalf of the ECTS Clinical Action Group.

Journal: European journal of endocrinology

Published: April 13, 2026

Pathophysiology, diagnosis and management of secondary osteoporosis.

Journal: Nature reviews. Endocrinology

Published: March 27, 2026

Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: February 21, 2026

Osteoimmunology: Can We Prevent Bone Loss in Rheumatoid Arthritis with Modern Antirheumatic Drugs?

Journal: Calcified tissue international

Published: December 21, 2025

The use of denosumab in rare bone diseases in adults: a systematic review from the ECTS Rare Bone Disease Action Group.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 13, 2025

The use of denosumab in rare bone diseases in adults: a systematic review from the ECTS Rare Bone Disease Action Group.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 13, 2025

How to optimize the use of anti-osteoporotic medication in clinical practice?

Journal: Expert opinion on pharmacotherapy

Published: December 06, 2025

The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture.

Journal: Expert opinion on drug discovery

Published: November 24, 2025

Bone Adverse Events in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Comprehensive Review of the Literature from the Clinical Action Group of the European Calcified Tissue Society.

Journal: Calcified tissue international

Published: November 09, 2025

Repurposing osteoporosis medications for other diseases: a narrative review by the European Calcified Tissue Society (ECTS).

Journal: Bone

Published: October 19, 2025